Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Equity Lifestyle Properties
ELS
$12.7B
| $13.5M | 0.01% |
172,725
+20,800
| +14% | +$1.7M |
|
1677
Tetra Tech
TTEK
$9.42B
| $13.5M | 0.01% |
451,660
+109,765
| +32% | +$3.01M |
|
1678
Zillow
ZG
$8.34B
| $13.5M | 0.01% |
151,985
+131,940
| +658% | +$13.5M |
|
|
VMW
1679
DELISTED
VMware, Inc
VMW
| $13.4M | 0.01% |
90,309
+44,662
| +98% | +$6.77M |
|
|
SNBR
1680
DELISTED
Sleep Number
SNBR
| $13.4M | 0.01% |
143,583
+24,741
| +21% | +$2.45M |
|
|
VNE
1681
DELISTED
Veoneer, Inc.
VNE
| $13.4M | 0.01% |
393,977
+345,142
| +707% | +$11M |
|
1682
CALL
Altria Group
MO
$114B
| $13.4M | 0.01% |
293,900
+162,600
| +124% | +$7.85M |
|
1683
CALL
GSK
GSK
$104B
| $13.4M | 0.01% |
+280,000
| New | +$14.1M |
|
|
MBT
1684
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $13.4M | 0.01% |
1,387,095
+652,105
| +89% | +$5.87M |
|
|
IPVI
1685
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
| $13.4M | 0.01% |
1,379,283
+1,000,000
| +264% | +$9.75M |
|
1686
Dr. Reddy's Laboratories
RDY
$10.3B
| $13.4M | 0.01% |
1,025,805
+775,690
| +310% | +$10.3M |
|
|
DNAB
1687
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| $13.4M | 0.01% |
1,352,399
-212,172
| -14% | -$2.09M |
|
|
APLS
1688
DELISTED
Apellis Pharmaceuticals
APLS
| $13.4M | 0.01% |
+405,382
| New | +$22.8M |
|
1689
CALL
Petrobras
PBR
$115B
| $13.3M | 0.01% |
1,291,100
| – | – |
|
1690
Albemarle
ALB
$15.7B
| $13.3M | 0.01% |
60,946
+42,306
| +227% | +$9.04M |
|
|
CTAQ
1691
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
| $13.3M | 0.01% |
1,365,533
| – | – |
|
1692
SITE Centers
SITC
$156M
| $13.3M | 0.01% |
1,106,858
-251,856
| -19% | -$3.05M |
|
1693
Prestige Consumer Healthcare
PBH
$2.44B
| $13.3M | 0.01% |
237,243
+203,276
| +598% | +$11.2M |
|
|
ATCO
1694
DELISTED
Atlas Corp.
ATCO
| $13.3M | 0.01% |
874,764
+433,643
| +98% | +$6.2M |
|
|
PARA
1695
CALL
DELISTED
Paramount Global Class B
PARA
| $13.3M | 0.01% |
336,100
-221,900
| -40% | -$9.04M |
|
1696
BellRing Brands
BRBR
$1.25B
| $13.3M | 0.01% |
431,274
-167,061
| -28% | -$5.35M |
|
1697
iShares MSCI Emerging Markets ETF
EEM
$31.3B
| $13.2M | 0.01% |
262,930
-176,573
| -40% | -$9.19M |
|
1698
First Merchants
FRME
$2.61B
| $13.2M | 0.01% |
316,571
+134,674
| +74% | +$5.48M |
|
1699
Extreme Networks
EXTR
$2.95B
| $13.2M | 0.01% |
1,344,549
+59,492
| +5% | +$628K |
|
1700
iShares MSCI Australia ETF
EWA
$1.36B
| $13.2M | 0.01% |
533,450
+130,706
| +32% | +$3.38M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.